Sonya Abraham

Sonya Abraham

Company: UCB

Job title: Head of New Treatment Strategies, Immune-Dermatology


She trained in Internal Medicine and Rheumatology in London, Oxford and Cambridge, UK and undertook visiting fellowships at Johns Hopkins, US. Her PhD was in cellular and molecular biology examining kinase pathways and the effects of corticosteroids. This was undertaken at the Kennedy Institute of Rheumatology and her mentor was Sir Ravinder Maini. She then went onto develop skills in translational medicine/clinical pharmacology and was awarded qualifications in pharmaceutical medicine. A successful PI and CI on first in human studies through to phase 4. She has held leadership roles at the Royal Society of Medicine and the National Institute of Health Research. An advocate of patient centric healthcare and has led on patient/carer engagement and involvement initiatives in autoimmune disease.


“Golden Age” in Dermatology Drug Development – What Lessons Can Be Learnt from Rheumatic Inflammatory Disease? 9:15 am

Exploring key advances and challenges in derm drug development Aspiring to personalized medicineRead more

day: Day Two

Industry Leaders Panel: Pioneering in the “Golden Age” in Dermatology 9:30 am

Exploring the “Golden Age” in dermatology drug development – key advances and challenges Discussing what success looks like in derm drug development What’s next? – exploring new indications, new targets, new personalized medicine approaches Addressing unmet need – discussing drug development in rare conditions  Navigating the fiercely competitive topical spaceRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.